Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice (Q41436628)

30 September 2017

title

Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice (English)

1 reference

30 September 2017

S F Little

1

1 reference

30 September 2017

W M Webster

2

1 reference

30 September 2017

H Wilhelm

3

1 reference

30 September 2017

D Fisher

4

1 reference

30 September 2017

S L W Norris

5

1 reference

30 September 2017

B S Powell

6

1 reference

30 September 2017

J Enama

7

1 reference

30 September 2017

J J Adamovicz

8

1 reference

30 September 2017

language of work or name

English

0 references

publication date

17 November 2009

1 reference

30 September 2017

1 reference

30 September 2017

volume

28

1 reference

30 September 2017

issue

4

1 reference

30 September 2017

page(s)

934-939

1 reference

Yersinia pestis--etiologic agent of plague

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

V antigen of Yersinia pestis inhibits neutrophil chemotaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Plague bacteria target immune cells during infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Effects of Fraction I from Yersinia pestis on Phagocytosis In Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Plague Immunization. I. Past and Present Trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Yersinia pestis outer membrane type III secretion protein YscC: expression, purification, characterization, and induction of specific antiserum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Immunization of mice with YscF provides protection from Yersinia pestis infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb/C mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Human immune response to a plague vaccine comprising recombinant F1 and V antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Development of a recombinant vaccine against aerosolized plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Modified caspase-3 assay indicates correlation of caspase-3 activity with immunity of nonhuman primates to Yersinia pestis infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Studies on the experimental epidemiology of respiratory infections. VIII. Experimental pneumonic plague in Macacus rhesus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Evaluation of quantitative anti-F1 IgG and anti-V IgG ELISAs for use as an in vitro-based potency assay of plague vaccine in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

A modified method to induce immune polyclonal ascites fluid in BALB/c mice using Sp2/0-Ag14 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

The Yersinia pestis caf1M1A1 fimbrial capsule operon promotes transmission by flea bite in a mouse model of bubonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

A single dose sub-unit vaccine protects against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Development of in vitro correlate assays of immunity to infection with Yersinia pestis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

7 January 2021

Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

7 January 2021

Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

7 January 2021

Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

7 January 2021

Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.143

7 January 2021

10.1016/J.VACCINE.2009.10.143

Identifiers

DOI

1 reference

30 September 2017

1 reference